...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: NIH Halts Large Cardiovascular Inflammation Reduction Trial (CIRT)
Reply New Message
Prev Message Back To Forum Threaded View Next Message

One more addition to the GLP1-R agonist list: Injectable semaglutide previously showed MACE reduction in SUSTAIN-6. Ongoing PIONEER-6 with oral semaglutide looks to be near completion and should be reading out soon too, potentially in 2018.

 

2 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply